Orchid Pharma Ltd
NSE :ORCHPHARMA BSE :524372 Sector : PharmaceuticalsBuy, Sell or Hold ORCHPHARMA? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
18 May 1075.10 (-1.68%) | 17 May 1093.45 (1.20%) | 16 May 1080.50 (-1.66%) | 15 May 1098.70 (8.28%) | 14 May 1014.65 (-0.02%) | 13 May 1014.85 (-1.91%) | 10 May 1034.65 (1.46%) | 09 May 1019.75 (-1.23%) | 08 May 1032.45 (3.70%) | 07 May 995.65 (-2.37%) | 06 May 1019.85 (-2.32%) | 03 May 1044.10 (-1.46%) | 02 May 1059.55 (-1.77%) | 30 Apr 1078.65 (-0.86%) | 29 Apr 1088.00 (0.34%) | 26 Apr 1084.35 (-0.74%) | 25 Apr 1092.40 (2.57%) | 24 Apr 1065.00 (0.84%) | 23 Apr 1056.10 (0.25%) | 22 Apr 1053.50 (-1.06%) | 19 Apr 1064.80 (-0.60%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bullish
Medium Term Investors
Neutral
Long Term Investors
Very Bullish
Moving Averages
5 DMA
Bullish
1071.25
10 DMA
Bullish
1044.71
20 DMA
Bullish
1054.27
50 DMA
Bullish
1065.9
100 DMA
Bullish
977.65
200 DMA
Bullish
763.83
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On May 18, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1123.8 | 1111.4 | 1083.5 | - | - |
R2 | 1111.4 | 1099.73 | 1080.7 | 1109.96 | - |
R1 | 1093.25 | 1092.52 | 1077.9 | 1090.37 | 1102.33 |
P | 1080.85 | 1080.85 | 1080.85 | 1079.41 | 1085.39 |
S1 | 1062.7 | 1069.18 | 1072.3 | 1059.82 | 1071.78 |
S2 | 1050.3 | 1061.97 | 1069.5 | 1048.86 | - |
S3 | 1032.15 | 1050.3 | 1066.7 | - | - |
Key Metrics
EPS
17.41
P/E
61.67
P/B
4.72
Dividend Yield
0%
Market Cap
5,453 Cr.
Face Value
10
Book Value
227.45
ROE
0.29%
EBITDA Growth
42.01 Cr.
Debt/Equity
0.45
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Orchid Pharma Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 168.69 | 250.84 | 184.81 | 207.11 | 228.21 |
PROFIT | 7.59 | 26.7 | 9.4 | 19.8 | 29.43 |
EPS | 1.86 | 14.49 | 1.85 | 4.3 | 6.18 |
Orchid Pharma Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 168.69 | 250.84 | 184.81 | 206.94 | 228.03 |
PROFIT | 6.73 | 26.72 | 10.78 | 20.24 | 30.55 |
EPS | 1.65 | 15.89 | 2.64 | 4.4 | 6.42 |
Profit & Loss (Figures in Rs. Crores)
Orchid Pharma Ltd Profit & Loss
Sep 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 2010.88 | 1893.37 | 904.92 | 804.22 | 695.72 | 791.28 | 526.41 | 482.36 | 654.09 | 746.02 | |
PROFIT | -609.27 | -310.04 | -226.56 | -409.18 | -352.81 | -131.52 | -131.16 | -118.41 | -2.46 | 6.32 | |
EPS | 0 | 0 | 0 | 0 | 0 | 7.8 | 0 | -28.55 | 0.39 | 11.88 |
Orchid Pharma Ltd Profit & Loss
Sep 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 1968.82 | 1882.85 | 888.65 | 780.78 | 661.47 | 781.08 | 525.56 | 472.85 | 636.67 | 746.02 | |
PROFIT | -571.56 | -304.43 | -221.72 | -402.29 | -355.32 | -125.99 | -149.93 | -118.13 | -5.32 | 14.19 | |
EPS | 0 | 0 | 0 | 0 | 0 | -11.36 | -36.71 | -28.7 | -1.18 | 13.28 |
Balance Sheet (Figures in Rs. Crores)
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Sep 2013 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 40.82 | 40.82 | 40.82 | 40.82 | 88.96 | 88.96 | 88.96 | 88.96 | 85.26 | 70.45 |
Reserves Total | 579.27 | 538 | 543.53 | 725.17 | -793 | -880.72 | -555.71 | -39.92 | 244.12 | 309.53 |
Equity Application Money | 68.56 | 68.56 | 68.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 688.65 | 647.38 | 652.91 | 765.99 | -704.04 | -791.76 | -466.75 | 49.04 | 329.38 | 379.98 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.62 |
Secured Loans | 264.15 | 207.58 | 389.24 | 491.92 | 3,091.65 | 3,064.84 | 3,104.83 | 2,872.29 | 2,984.88 | 2,336.69 |
Unsecured Loans | 67.19 | 60.38 | 63.5 | 74.47 | 138.31 | 137.11 | 1.33 | 342.3 | 225.78 | 867.46 |
Total Debt | 331.34 | 267.96 | 452.74 | 566.39 | 3,229.96 | 3,201.95 | 3,106.16 | 3,214.59 | 3,210.66 | 3,204.15 |
Other Liabilities | 12.6 | 11.01 | 11.54 | 11.79 | 7.7 | 7.48 | 5.92 | 3.73 | 4.18 | 5.24 |
Total Liabilities | 1,032.59 | 926.35 | 1,117.19 | 1,344.17 | 2,533.62 | 2,417.67 | 2,645.33 | 3,267.36 | 3,544.22 | 3,589.99 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 1,220.56 | 1,176.39 | 1,176.1 | 1,247.11 | 1,519.48 | 1,519.49 | 1,636.89 | 3,005.87 | 3,002.15 | 3,772.17 |
Less: Accumulated Depreciation | 647.47 | 592.68 | 505.66 | 389.18 | 263.22 | 133.28 | 140.34 | 1,369.04 | 1,206.95 | 1,188.6 |
Net Block | 573.09 | 583.71 | 670.44 | 857.93 | 1,256.26 | 1,386.21 | 1,496.55 | 1,636.83 | 1,795.2 | 2,583.57 |
Capital Work in Progress | 46.46 | 9.78 | 7.43 | 25.61 | 278.16 | 271.53 | 288.31 | 280.4 | 281.51 | 360.42 |
Investments | 44.44 | 45.49 | 15.43 | 0.34 | 0.47 | 1.07 | 1.14 | 0.81 | 0.81 | 0.95 |
Inventories | 228.74 | 172.66 | 152.89 | 141.69 | 169.77 | 193.74 | 211.25 | 241.85 | 251.93 | 506.24 |
Sundry Debtors | 215.19 | 170.57 | 135.7 | 67.97 | 119.89 | 119.51 | 164.65 | 310.07 | 256.57 | 179.06 |
Cash and Bank Balance | 30.63 | 8.06 | 19.91 | 174.04 | 325.52 | 305.55 | 257.06 | 314.94 | 390.57 | 23.42 |
Loans and Advances | 26.45 | 46.37 | 226.34 | 185.62 | 152.27 | 60.14 | 42.16 | 384.33 | 379.06 | 392.7 |
Total Current Assets | 501.01 | 397.65 | 534.84 | 569.32 | 767.46 | 678.95 | 675.12 | 1,251.2 | 1,278.12 | 1,101.42 |
Current Liabilities | 185.9 | 177.98 | 113.31 | 109.27 | 536.56 | 703.44 | 559.51 | 456.35 | 353.73 | 872.5 |
Provisions | 3.49 | 3.01 | 3.52 | 3.25 | 3.63 | 1.03 | 1.33 | 44.22 | 52.23 | 31.17 |
Total Current Liabilities & Provisions | 189.39 | 180.99 | 116.84 | 112.52 | 540.2 | 704.47 | 560.84 | 500.57 | 405.96 | 903.67 |
Net Current Assets | 311.62 | 216.66 | 418 | 456.8 | 227.26 | -25.52 | 114.29 | 750.63 | 872.16 | 197.75 |
Deferred Tax Assets | 86.11 | 82.83 | 149.34 | 197.5 | 240.32 | 94.14 | 0 | 0 | 0 | 55.1 |
Deferred Tax Liability | 89.33 | 86.06 | 152.57 | 200.72 | 243.54 | 97.37 | 49.42 | 94.14 | 111.21 | 212.47 |
Net Deferred Tax | -3.22 | -3.23 | -3.23 | -3.22 | -3.22 | -3.23 | -49.42 | -94.14 | -111.21 | -157.37 |
Other Assets | 60.2 | 73.94 | 9.11 | 6.7 | 774.68 | 787.62 | 794.47 | 692.83 | 705.75 | 604.68 |
Total Assets | 1,032.6 | 926.35 | 1,117.19 | 1,344.17 | 2,533.61 | 2,417.67 | 2,645.33 | 3,267.36 | 3,544.23 | 3,590 |
Contingent Liabilities | 41.95 | 42.88 | 45.12 | 0 | 142.9 | 161.53 | 181.21 | 71.32 | 107.03 | 168.28 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Sep 2013 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 40.82 | 40.82 | 40.82 | 40.82 | 88.96 | 88.96 | 88.96 | 88.96 | 85.26 | 70.45 |
Reserves Total | 622.59 | 568.58 | 571.96 | 688.45 | -843.95 | -763.1 | -431.88 | 82.17 | 354.14 | 417.71 |
Equity Application Money | 68.56 | 68.56 | 68.56 | 68.56 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 731.97 | 677.96 | 681.34 | 797.83 | -754.99 | -674.14 | -342.92 | 171.13 | 439.4 | 488.16 |
Secured Loans | 222.59 | 170.63 | 366.84 | 491.92 | 3,091.65 | 3,064.84 | 3,104.83 | 3,075.55 | 3,054.94 | 2,336.68 |
Unsecured Loans | 108.75 | 97.32 | 85.9 | 74.47 | 138.31 | 137.11 | 1.33 | 138.87 | 155.72 | 867.46 |
Total Debt | 331.34 | 267.95 | 452.74 | 566.39 | 3,229.96 | 3,201.95 | 3,106.16 | 3,214.42 | 3,210.66 | 3,204.14 |
Other Liabilities | 12.6 | 11.01 | 11.54 | 11.79 | 7.7 | 7.48 | 5.92 | 3.73 | 4.18 | 5.24 |
Total Liabilities | 1,075.91 | 956.92 | 1,145.62 | 1,376.01 | 2,482.67 | 2,535.29 | 2,769.16 | 3,389.28 | 3,654.24 | 3,697.54 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 1,220.45 | 1,176.26 | 1,175.97 | 1,246.98 | 1,424.57 | 1,424.57 | 1,540.43 | 2,893.19 | 2,889.7 | 3,659.71 |
Less : Accumulated Depreciation | 647.39 | 592.6 | 505.58 | 389.12 | 263.22 | 133.29 | 138.72 | 1,352.83 | 1,192.6 | 1,176.9 |
Net Block | 573.06 | 583.66 | 670.39 | 857.86 | 1,161.35 | 1,291.28 | 1,401.71 | 1,540.36 | 1,697.1 | 2,482.81 |
Capital Work in Progress | 46.09 | 9.78 | 7.43 | 25.61 | 278.16 | 271.53 | 288.31 | 280.4 | 281.51 | 360.42 |
Investments | 50.12 | 49.01 | 15.43 | 0.34 | 0.47 | 124.77 | 124.84 | 124.65 | 124.65 | 124.18 |
Inventories | 228.74 | 172.66 | 150.57 | 140.78 | 167.11 | 184.94 | 197.45 | 210.34 | 242.28 | 500.08 |
Sundry Debtors | 211.91 | 160.23 | 131.96 | 66.38 | 140.73 | 145.07 | 208.07 | 375.44 | 290.16 | 183.7 |
Cash and Bank Balance | 22.34 | 4.21 | 18.97 | 172.32 | 324.17 | 301.04 | 256.04 | 313.11 | 389.57 | 22.4 |
Loans and Advances | 30.81 | 45.99 | 225.73 | 185.29 | 151.45 | 59.75 | 41.5 | 425.23 | 424.78 | 445.52 |
Total Current Assets | 493.79 | 383.08 | 527.23 | 564.77 | 783.46 | 690.8 | 703.06 | 1,324.12 | 1,346.79 | 1,151.69 |
Current Liabilities | 140.64 | 131.04 | 72.1 | 67.51 | 503.73 | 671.21 | 538.43 | 434.88 | 338.17 | 836.61 |
Provisions | 3.49 | 3.01 | 3.52 | 3.25 | 3.63 | 1.03 | 1.33 | 44.22 | 52.23 | 31.17 |
Total Current Liabilities & Provisions | 144.12 | 134.05 | 75.62 | 70.76 | 507.37 | 672.24 | 539.76 | 479.1 | 390.4 | 867.78 |
Net Current Assets | 349.67 | 249.03 | 451.61 | 494.01 | 276.09 | 18.56 | 163.3 | 845.02 | 956.39 | 283.91 |
Deferred Tax Assets | 86.11 | 82.83 | 149.34 | 197.5 | 240.32 | 0 | 0 | 0 | 0 | 54.58 |
Deferred Tax Liability | 89.33 | 86.06 | 152.57 | 200.72 | 243.54 | 3.23 | 49.42 | 94.14 | 111.39 | 212.47 |
Net Deferred Tax | -3.22 | -3.23 | -3.23 | -3.22 | -3.22 | -3.23 | -49.42 | -94.14 | -111.39 | -157.89 |
Other Assets | 60.2 | 68.67 | 4 | 1.41 | 769.81 | 832.39 | 840.43 | 692.99 | 705.97 | 604.12 |
Total Assets | 1,075.92 | 956.92 | 1,145.63 | 1,376.01 | 2,482.66 | 2,535.3 | 2,769.16 | 3,389.28 | 3,654.23 | 3,697.55 |
Contingent Liabilities | 38.16 | 42.88 | 45.12 | 0 | 142.9 | 161.53 | 181.21 | 71.32 | 107.03 | 187.06 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 46.32 |
Depreciation | 54.79 |
Interest (Net) | 31.61 |
P/L on Sales of Assets | -39.99 |
P/L on Sales of Invest | -0.02 |
Prov. and W/O (Net) | 1.19 |
P/L in Forex | 1.64 |
Total Adjustments (PBT and Ext... | 51.38 |
Operating Profit before Workin... | 97.7 |
Trade and 0ther Receivables | -41.65 |
Inventories | -56.08 |
Trade Payables | 13.91 |
Total Adjustments (OP before W... | -79.06 |
Cash Generated from/(used in) ... | 18.64 |
Direct Taxes Paid | -0.3 |
Total Adjustments(Cash Generat... | -0.3 |
Cash Flow before Extraordinary... | 18.34 |
Net Cash from Operating Activi... | 18.34 |
Purchased of Fixed Assets | -84.91 |
Sale of Fixed Assets | 58.55 |
Purchase of Investments | -1.03 |
Interest Received | 0.46 |
Net Cash used in Investing Act... | -31.21 |
Proceed from 0ther Long Term B... | 173.2 |
Of the Long Tem Borrowings | -109.81 |
Interest Paid | -32.23 |
Net Cash used in Financing Act... | 31.17 |
Net Profit before Tax and Extr... | 54.19 |
Depreciation | 54.79 |
Interest (Net) | 31.61 |
P/L on Sales of Assets | -39.99 |
P/L on Sales of Invest | -0.02 |
Prov. and W/O (Net) | 1.19 |
P/L in Forex | 6.51 |
Total Adjustments (PBT and Ext... | 54.1 |
Operating Profit before Workin... | 108.29 |
Trade and 0ther Receivables | -48.7 |
Inventories | -56.08 |
Trade Payables | 15.6 |
Total Adjustments (OP before W... | -94.6 |
Cash Generated from/(used in) ... | 13.69 |
Direct Taxes Paid | -0.3 |
Total Adjustments(Cash Generat... | -0.3 |
Cash Flow before Extraordinary... | 13.39 |
Net Cash from Operating Activi... | 13.39 |
Purchased of Fixed Assets | -84.55 |
Sale of Fixed Assets | 58.55 |
Purchase of Investments | -1.04 |
Interest Received | 0.62 |
Net Cash used in Investing Act... | -26.7 |
Proceed from Short Tem Borrowi... | 173.2 |
Of the Long Tem Borrowings | -109.81 |
Interest Paid | -32.23 |
Net Cash used in Financing Act... | 31.17 |
Company Details
Registered Office |
|
Address | Orchid Towers Nungambakkam, 313 Valluvar Kottam High Road |
City | Chennai |
State | Tamil Nadu |
Pin Code | 600034 |
Tel. No. | 91-44-28211000/28230000 |
Fax. No. | 91-44-28211002 |
corporate@orchidpharma.com | |
Internet | http://www.orchidpharma.com |
Registrars |
|
Address | Orchid Towers Nungambakkam |
City | Chennai |
State | Tamil Nadu |
Pin Code | 600034 |
Tel. No. | 91-44-28211000/28230000 |
Fax. No. | 91-44-28211002 |
corporate@orchidpharma.com | |
Internet | http://www.orchidpharma.com |
Management |
|
Name | Designation |
Tanu Singla | Independent Director |
Dharam Vir | Independent Director |
Mudit Tandon | Independent Director |
Manoj Goyal | Independent Director |
Manish Dhanuka | Managing Director |
Mridul Dhanuka | Whole-time Director |
Ram Gopal Agarwal | Chairman (Non-Executive) |